Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China.
Research context
Shandong Jincheng Pharmaceutical Group Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Basic Materials
- Industry
- Chemicals
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Shandong Jincheng Pharmaceutical Group Co., Ltd is currently in a long term uptrend where the price is trading 34.9% above its 200 day moving average.
From a valuation standpoint, the stock is 17.8% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 3.3.
Shandong Jincheng Pharmaceutical Group Co., Ltd's total revenue sank by 2.8% to $664M since the same quarter in the previous year.
Its net income has dropped by 64.9% to $39M since the same quarter in the previous year.
Finally, its free cash flow grew by 26.2% to $122M since the same quarter in the previous year.
Based on the above factors, Shandong Jincheng Pharmaceutical Group Co., Ltd gets an overall score of 3/5.